MANUEL
PRAGA TERENTE
Profesor emérito
Hospital Universitario Virgen del Rocío
Sevilla, EspañaPublicacions en col·laboració amb investigadors/es de Hospital Universitario Virgen del Rocío (19)
2024
-
Complement alternative pathway determines disease susceptibility and severity in antineutrophil cytoplasmic antibody (ANCA)–associated vasculitis
Kidney International, Vol. 105, Núm. 1, pp. 177-188
-
Sodium-glucose cotransporter 2 inhibition in primary and secondary glomerulonephritis
Nephrology Dialysis Transplantation, Vol. 39, Núm. 2, pp. 328-340
2023
-
Clinical Profiles and Patterns of Kidney Disease Progression in C3 Glomerulopathy
Kidney360, Vol. 4, Núm. 5, pp. 659-672
-
Recurrence of immune complex and complement-mediated membranoproliferative glomerulonephritis in kidney transplantation
Nephrology Dialysis Transplantation, Vol. 38, Núm. 1, pp. 222-235
-
Thrombotic microangiopathy in patients with malignant hypertension
Nephrology Dialysis Transplantation, Vol. 38, Núm. 5, pp. 1217-1226
2022
-
C3 glomerulopathy associated with monoclonal gammopathy: impact of chronic histologic lesions and beneficial effects of clone-targeted therapies
Nephrology Dialysis Transplantation, Vol. 37, Núm. 11, pp. 2128-2137
-
Development and validation of a nomogram to predict kidney survival at baseline in patients with C3 glomerulopathy
Clinical Kidney Journal, Vol. 15, Núm. 9, pp. 1737-1746
-
IgA Nephropathy Is the Most Common Underlying Disease in Patients With Anticoagulant-Related Nephropathy
Kidney International Reports, Vol. 7, Núm. 4, pp. 831-840
-
Longitudinal change in proteinuria and kidney outcomes in C3 glomerulopathy
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, Vol. 37, Núm. 7, pp. 1270-1280
2021
-
The STARMEN trial indicates that alternating treatment with corticosteroids and cyclophosphamide is superior to sequential treatment with tacrolimus and rituximab in primary membranous nephropathy
Kidney International, Vol. 99, Núm. 4, pp. 986-998
-
Validation of a Histologic Scoring Index for C3 Glomerulopathy
American Journal of Kidney Diseases, Vol. 77, Núm. 5, pp. 684-695.e1
2020
-
Mycophenolate mofetil in c3 glomerulopathy and pathogenic drivers of the disease
Clinical Journal of the American Society of Nephrology, Vol. 15, Núm. 9, pp. 1287-1298
2019
-
Complement activation and thrombotic microangiopathies
Clinical Journal of the American Society of Nephrology, Vol. 14, Núm. 12, pp. 1719-1732
-
Severe and malignant hypertension are common in primary atypical hemolytic uremic syndrome
Kidney International, Vol. 96, Núm. 4, pp. 995-1004
2018
-
A retrospective study of pregnancy-associated atypical hemolytic uremic syndrome
Kidney International, Vol. 93, Núm. 2, pp. 450-459
2015
-
Effectiveness of mycophenolate mofetil in C3 glomerulonephritis
Kidney International, Vol. 88, Núm. 5, pp. 1153-1160
2010
-
Spontaneous remission of nephrotic syndrome in idiopathic membranous nephropathy
Journal of the American Society of Nephrology, Vol. 21, Núm. 4, pp. 697-704
2005
-
Farmacogenética del sistema de la angiotensina en la nefropatía no diabética
Nefrologia, Vol. 25, Núm. 4, pp. 381-386
2003
-
Antiproteinuric efficacy of losartan in comparison with amplodipine in non-diabetic proteinuric renal diseases: A double-blind, randomized clinical trial
Nephrology Dialysis Transplantation, Vol. 18, Núm. 9, pp. 1806-1813